PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner,

Size: px
Start display at page:

Download "PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner,"

Transcription

1 PERCEPTION OF CVD RISK FACTORS BY DIFFERENT STAKEHOLDERS - DOCTORS, MEDICAL STUDENTS, GENERAL PUBLIC, POLITICIANS, JOURNALISTS Professor ŽeljkoReiner, MD,PhD,FRCP(Lond),FESC,FACC University Hospital Center Zagreb, University of Zagreb, Zagreb School of Medicine, Croatia

2 CAUSES OF DEATH IN CROATIA IN 2008 Izvor podataka: Državni zavod za statistiku, Hrvatski zavod za javno zdravstvo

3 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA GENERAL POPULATION A questionnaire with 25 multiple choice questions In 37 pharmacies covering the whole area of Croatia consecutively to all customers willing to answer 883 respondents (questionnaires finished) September 1 to November 30, 2007

4 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA PHYSICIANS In Croatia physicians (1753 GPs and 927 specialists in GP/family medicine, 987 general internists, 203 cardiologists) randomly recruited using national physicians registry and professional societies directories 5 regions, all cardiologists, every third GP/FP, every fifth internist A questionnaire with 25 multiple choice questions 1382 physicians (930 GP/FP, 165 cardiologists, 213 internists) answered March 1 to June 30, 2008

5 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA MEDICAL STUDENTS A questionnaire with 25 multiple choice questions 443 medical students at the beginning of the study and at the end of the study On the enrolment day and graduation day September 2008 School of Medicine, University of Zagreb

6 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA MEMBERS OF PARLIAMENT 77 out of 141 members of the Croatian Parliament - Sabor One day during the Parliament session in the Houses of Parliament 2008 A questionnaire with 25 multiple choice questions

7 PERCRO Study - PERCEPTION OF CARDIOVASCULAR RISK FACTORS IN CROATIA JOURNALISTS A questionnaire with 25 multiple choice questions 129 journalists from daily press newspaper, TV, radio In the Croatian Press Association House One day in 2008

8 Age Groups Distribution (years) 46,9% 35,9% 31,5% 24,0% 26,2% 28,8% 27,1% 27,1% 22,8% 19,0% 23,3% 23,9% General Pupolation Journalists Politicians Doctors 16,3% 7,9% 1,6% 1,1% 0% 0% 0% 0% 5,4% 6,8% 8,7% 3,9% 9,6% 2,2% 0% 0% 0% 0% 0% 0% >85 Medical Students all belong to the age group

9 Groups by Gender General Population Journalists 47% 53% 44% 56% Medical Students Politicians 67,42% 32,58% 59,72% 40,28% Male Female

10 Knowledge of Blood Pressure General Population Journalists 13% 26% 74% 87% Know Their Blood Pressure Don't know/no Answer Medical Students Politicians 18% 82% 10% 90%

11 Knowledge of Cholesterol Levels General Population Journalists 58% 42% 57% 43% Know Their Level Don't Know Level/No Answer Medical Students Politicians 26% 21% 74% 79%

12 Awareness of Bad Cholesterol 83,5% 56,8% 54,3% General Population Journalists Medical Students Politicians 31,0% 14,7% 10,9% 9,9% 12,0% 5,3% 26,4% 27,3% 20,2% 14,1% 8,7% 7,8% 5,3% 5,3% 2,7% 2,0% 1,8% HDL Cholesterol LDL Cholesterol Triglycerides None of Mentioned No Answer/Invalid Answer

13 Awareness of Good Cholesterol 82,4% 62,3% Population Journalists Medical Students Politicians 45,0% 50,0% 23,9% 26,4% 26,0% 16,3% 12,0% 9,8% 5,2% 2,2% 3,1% 0,9% 1,3% 14,1% 9,3% 5,2% 2,5% 2,3% HDL Cholesterol LDL Cholesterol Triglycerides None of Mentioned No Answer/Invalid Answer

14 Fear of Listed Diseases 63,9% 40,0% 48,6% 42,9% General Population Journalists Medical Students Politicians 28,6% 14,3% 14,5% 18,6% 10,4% 13,5% 13,0% 5,1% 0% 21,6% 23,3% 16,5% 9,3% 7,0% 0,0% 2,0% 2,3% 0% 0,0% 0,2% 0,8% 1,1% 1,3% 1,8% Cancer Cerebrovascular disease AIDS Heart disease Liver disease Tuberculosis and pulmonary disease No Answer/ Don'tknow

15 Awareness of the Leading Cause of Death Traffic Accidents Cancer 6,2% 10,8% 6,2% 10,5% 10,6% 16,3% 16,3% 27,0% Politicians Medical Students Journalists Population Cerebrovascular Disease 5,4% 5,9% 5,4% 8,6% AIDS 0,0% 0,2% 0,0% 0,8% Heart Disease 36,1% 53,5% 53,5% 72,0% Liver Cirrhosis Tuberculosis/Pulmonary Disease Don't Know/No Answer 0,0% 0,2% 0,0% 0,3% 0,0% 0,0% 0,8% 0,2% 0,2% 17,7% 17,8% 16,4%

16 Total cholesterol p=0,764 Kruskal-Wallis test

17 Triglycerides p=0,767 Kruskal-Wallis test

18 HDL - cholesterol Population : Parliament p=0,540 Population : Journalists p=0,003 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

19 LDL - cholesterol Population : Parliament p=0,999 Population : Journalists p=0,027 Journalists : Parliament p=0,045 Mann-Whitney test with correction for multiple testing

20 hs-crp Population : Parliament p=0,999 Population : Journalists p=0,069 Journalists : Parliament p=0,042 Mann-Whitney test with correction for multiple testing

21 Glucose Population : Parliament p=0,999 Population : Journalists p=0,015 Journalists : Parliament p=0,100 Mann-Whitney test with correction for multiple testing

22 HbA1c Population : Parliament p=0,876 Population : Journalists p=0,003 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

23 Height Population : Parliament p=0,003 Population : Journalists p=0,390 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

24 Weight Population : Parliament p=0,003 Population : Journalists p=0,999 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

25 BMI Population : Parliament p=0,003 Population : Journalists p=0,681 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

26 Waist Population : Parliament p=0,003 Population : Journalists p=0,999 Journalists : Parliament p=0,003 Mann-Whitney test with correction for multiple testing

27 Smoking Habits 75% 79% 57% 52% General Population Journalists Medical Students 28% 30% Politicians 22% 18% 15% 18% 3% 3% Smoker Former smoker Non-smoker

28 GP informed about the CV risks High Cholesterol Levels 30,9% 44,1% High Blood Pressure 27,0% 42,6% Smoking 20,6% 22,0% Obesity/Overweight 14,7% 21,1% None 38,2% 52,8% Population Journalists

29 Doctors by Speciality 18,8% 3,0% 12,2% 68,9% Family Doctors Cardiologists Internists Neurologists

30 Following of CVD Prevention Guidelines by Speciality International Atherosclerosis Society guidelines 9,3% 18,4% 16,7% US Guidelines 1,9% 1,4% 1,4% Joint European guidelines from 2007 Joint European guidelines from ,3% 7,1% 3,8% 59,6% 59,1% 71,3% Cardiologists Internists Primary care Institution guidelines 0,9% 2,8% 1,4% Own judgment 7,4% 10,6% 17,5%

31 Guidelines usefulness Do not know guidelines 1,8% 1,2% 1,2% Not useful Fairly useful 0,5% 0,6% 0,3% 20,9% 15,4% 22,9% Cardiologists Internists Primary care Very useful 76,8% 82,7% 75,5%

32 Knowledge of Joint European guidelines recommendation for HDL-chol. in women < 1.2 mmol/l 3,8% 2,5% 6,3% > 1.2 mmol/l 59,2% 58,7% 69,7% < 1.0 mmol/l > 1.0 mmol/l 2,5% 7,0% 6,5% 23,6% 17,4% 21,0% Cardiologists Internists Primary care > 0.9 mmol/l 5,1% 3,0% 3,6% < 0.9 mmol/l 5,7% 0,5% 3,9%

33 Knowledge of Joint European CVD Prevention Guidelines recommendation for blood pressure in high risk patients 120/80 mmhg 38,2% 34,5% 50,5% 130/85 mmhg 39,7% 43,3% 48,5% Cardiologists Internists 150/90 mmhg 8,9% 17,8% 14,1% Primary care 140/90 mmhg 0,6% 2,9% 0,9%

34 Knowledge on optimal blood pressure in high risk patients 37,1% 42,1% 40,0% 45,2% Medical Students Doctors 15,7% 11,2% 6,3% 1,6% <150/90 <140/90 <130/85 <120/80

35 Knowledge of recommended HDLcholesterol in women (mmol/l) 60,2% 34,7% Medical Students Doctors 22,2% 21,1% 14,7% 3,7% 3,6% 3,9% 13,5% 5,9% 11,2% 5,3% <0,9 >0,9 >1,0 <1,0 >1,2 <1,2

36 Knowledge on recommended LDL-cholesterol in patients with diabetes (mmol/l) 56,1% 24,3% 20,5% 30,4% 30,0% 24,8% Medical Students Doctors 7,5% 6,4% <5 <4 <3 <2,5

37 Lowering cholesterol with diet 68,4% 54,5% Medical Student Doctors 26,7% 18,9% 11,9% 9,7% 5,0% 2,7% 1,9% 0,3% 2-3% 10-15% about 50% 50-70% up to 90%

38 Broj ispitanika (%) Do you Believe you Treat Well Your Patients with Hyperlipidemia? Sm atrate li da dobro liječite svoje bolesnike hipelipidem ijom Liječnici OM (N=556) Kardiolozi (N=134) da ne ne znam

39

40

41

42

43 Thank you!

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416). Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.

More information

ESC/EAS GUIDELINES ON MANAGEMENT OF DYSLIPIDEMIAS IN CLINICAL PRACTICE

ESC/EAS GUIDELINES ON MANAGEMENT OF DYSLIPIDEMIAS IN CLINICAL PRACTICE ESC/EAS GUIDELINES ON MANAGEMENT OF DYSLIPIDEMIAS IN CLINICAL PRACTICE Professor Željko Reiner, MD, PhD,FRCP(Lond), FESC Director, University Hospital Center Zagreb School of Medicine, University of Zagreb,

More information

ESC/EAS Guidelines for the Management of Dyslipidaemias

ESC/EAS Guidelines for the Management of Dyslipidaemias ESC/EAS Guidelines for the Management of Dyslipidaemias Professor Željko Reiner, MD, PhD, FRCP(Lond), FESC, FACC University Hospital Center Zagreb School of Medicine, University of Zagreb, Croatia Declaration

More information

Deprivation Study. The Freiburg Study

Deprivation Study. The Freiburg Study The Freiburg Study Deprivation Study Free Radicals Inflammation (hs-crp) Blood Pressure (Systolic, Diastolic) Blood Lipids (Cholesterol, Triglycerides) Energy Utilization (Heart Rate) Sugar Metabolism

More information

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs

More information

Cardiovascular Risk Assessment and Management Making a Difference

Cardiovascular Risk Assessment and Management Making a Difference Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy

More information

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values

More information

BEST PRACTICE MANAGEMENT: CARDIOVASCULAR RISKS

BEST PRACTICE MANAGEMENT: CARDIOVASCULAR RISKS BEST PRACTICE MANAGEMENT: CARDIOVASCULAR RISKS Neil R Poulter ICCH, Imperial College London BHIVA: October 10th, 2008 Background CVD is the biggest single killer in the world CVD rates are increasing High

More information

ESPEN Congress Florence 2008

ESPEN Congress Florence 2008 ESPEN Congress Florence 2008 Severe obesity - Session organised in conjunction with ASPEN The SOS study Setting the Scene A. Thorell (Sweden) The SOS study Setting the Scene Anders Thorell MD, PhD Associate

More information

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients

More information

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein

More information

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register

National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register The above graph shows a decrease in the number of patients on the

More information

Obesity Prevention and Control: Provider Education with Patient Intervention

Obesity Prevention and Control: Provider Education with Patient Intervention Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist

More information

Director, Employee Health & Productivity. Coordinator, Employee Health & Productivity

Director, Employee Health & Productivity. Coordinator, Employee Health & Productivity Director, Employee Health & Productivity Coordinator, Employee Health & Productivity Table 2:. ChartE: Female HDL Cholesterol Risk Levels Optimal Borderline High Risk 80% 60% 40% 20% 0% LDL Cholesterol

More information

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li

More information

2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE

2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE 2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE Massimo F Piepoli, MD, PhD, FESC, Piacenza, Italy on behalf of the 6 th Joint Task Force 2 3 Guidelines still based upon the principles of

More information

Plasma Lipids and Global Cardiovascular Risk

Plasma Lipids and Global Cardiovascular Risk Plasma Lipids and Global Cardiovascular Risk Ian Graham Chair JTF4 on the Prevention of CVD and PIC Member ESC/EAS Lipid Guidelines with special thanks to Željko Reiner, Trinity College Dublin- and Zagreb

More information

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

Cardiovascular Disease Risk Behaviors of Nursing Students in Nursing School

Cardiovascular Disease Risk Behaviors of Nursing Students in Nursing School International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2018, 7(8): 16-33 I J M R

More information

Croatian National Action Network Bone and Joint Decade A 10-YEAR REPORT

Croatian National Action Network Bone and Joint Decade A 10-YEAR REPORT HRVATSKI NACIONALNI ODBOR DESETLJEĆE KOSTIJU I ZGLOBOVA 2000-2010. CROATIAN NATIONAL ACTIVE NETWORK THE BONE AND JOINT DECADE 2000-2010. Dubrava University Hospital, Avenija Gojka Šuška 6 10 040 Zagreb

More information

Diabetes Passport. East Coast Area Diabetes Integrated Care

Diabetes Passport. East Coast Area Diabetes Integrated Care Diabetes Passport East Coast Area Diabetes Integrated Care Personal Details Name: Address: Developed by East Coast Area Diabetes Programme (ECAD), 2014. Thanks to Beaumont Hospital for allowing us to use

More information

Depok-Indonesia STEPS Survey 2003

Depok-Indonesia STEPS Survey 2003 The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural

More information

EuroPRevent Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice

EuroPRevent Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice EuroPRevent 2010 Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice G. De Backer Ghent University Ghent, Belgium May 5-8 2010, Prague Czech Republic G. De

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Metabolic Syndrome in Asians

Metabolic Syndrome in Asians Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

Disclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?

Disclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space? Disclosures JUPITER: The final frontier in statin utilization or an idea from outer space? Kathy E. Komperda, PharmD, BCPS Midwestern University Chicago College of Pharmacy kkompe@midwestern.edu 4/25/09

More information

Patient is healthy with no chronic disease or significant risk factors [16%].

Patient is healthy with no chronic disease or significant risk factors [16%]. AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II

More information

ASSeSSing the risk of fatal cardiovascular disease

ASSeSSing the risk of fatal cardiovascular disease ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril

More information

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Dr Kornelia Kotseva National Heart & Lung Insitute Imperial College London, UK on behalf of all investigators participating

More information

PLEASE REMEMBER TO BRING TO EACH APPOINTMENT

PLEASE REMEMBER TO BRING TO EACH APPOINTMENT PLEASE REMEMBER TO BRING TO EACH APPOINTMENT Conversion table for HbA1c% to mmol/mol Old DCCT aligned HbA1c(%) New IFCC HbA1c (mmol/mol) 4.0 20 5.0 31 6.0 42 6.5 48 7.0 53 7.5 59 8.0 64 9.0 75 10.0 86

More information

Prof Rob Doughty Heart Foundation Chair Heart Health University of Auckland. Dr Fraser Hamilton. General Practitioner Heart Foundation Hamilton

Prof Rob Doughty Heart Foundation Chair Heart Health University of Auckland. Dr Fraser Hamilton. General Practitioner Heart Foundation Hamilton Prof Rob Doughty Heart Foundation Chair Heart Health University of Auckland Dr Fraser Hamilton General Practitioner Heart Foundation Hamilton 14:00-14:55 WS #49: Controversies in Cardiovascular Disease

More information

WIN QUARTERLY UTILIZATION REPORT 7/1/2010 TO 12/31/2010. EXPERTISE PARTNERSHIP V A L U E April 20, 2011

WIN QUARTERLY UTILIZATION REPORT 7/1/2010 TO 12/31/2010. EXPERTISE PARTNERSHIP V A L U E April 20, 2011 WIN QUARTERLY UTILIZATION REPORT 7/1/2010 TO 12/31/2010 EXPERTISE PARTNERSHIP V A L U E April 20, 2011 T R E N D S A N A L Y S I S S T A T I S T I C S P L A N N I N G T O O L S Participation Mass Screening

More information

Adult Pre Participation Screening and Exercise Prescription Practicum

Adult Pre Participation Screening and Exercise Prescription Practicum Adult Pre Participation Screening and Exercise Prescription Practicum Objectives of this exercise: To administer pre participation screening and risk stratification for clients To write an appropriate

More information

Mississippi Stroke Systems of Care

Mississippi Stroke Systems of Care Stroke Initiatives Mississippi State Department of Health Cassandra Dove, Chronic Disease Bureau 19 th Annual Stroke Belt Consortium March 1, 2014 Mississippi Stroke Systems of Care Heart Disease and Stroke

More information

Controversies in Preventative Cardiology

Controversies in Preventative Cardiology Controversies in Preventative Cardiology Francisco Lopez-Jimenez, M.D., M.Sc, FACC, FAHA Professor of Medicine, Mayo Medical School Chair, Division of Preventive Cardiology Co-Director, Artificial Intelligence

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure

Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure CI Liakos, 1 EA Sanidas, 1 DN Perrea, 1 V Gennimata, 1 V Chantziara, 1 CA Grassos, 2 N-A Viniou, 1 JD Barbetseas,

More information

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate

More information

DIABETES. A growing problem

DIABETES. A growing problem DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought

More information

Corporate Health Screening

Corporate Health Screening Corporate Health Screening What should I look out for? Presented by: Dr Wee Wei Keong Director Health for Life Programme WHAT IS HEALTH SCREENING? Tests/procedures carried out to detect a condition/disease

More information

CARE PATHWAYS. Allyson Ashley

CARE PATHWAYS. Allyson Ashley CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

Prevention in Europe

Prevention in Europe Prevention in Europe Geneviève Derumeaux Créteil University, France Ian M Graham Trinity College, Dublin ESC: 2016 Lipid guidelines 2016 Joint Prevention Guidelines Cardiovascular disease in Europe Nick

More information

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain

More information

THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT

THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT Siti Hajar MH 1, Harmy MY 1, Norhayati MN 1, Aida HGR 2, Hamid JJM 3 Department

More information

290 Biomed Environ Sci, 2016; 29(4):

290 Biomed Environ Sci, 2016; 29(4): 290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur

More information

Case Study: Chris Arden. Peripheral Arterial Disease

Case Study: Chris Arden. Peripheral Arterial Disease Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she

More information

John s Labs & Tests (for December 1, 2012)

John s Labs & Tests (for December 1, 2012) 4 John s Labs & Tests (for December 1, ) Page 1 of 2 You had the following labs/studies performed: Ankle Brachial Pressure Index is the ratio of blood pressure in your legs divided by the blood pressure

More information

Health First. New Health Bucks Program MANATEE YOURCHOICE HEALTH PLAN

Health First. New Health Bucks Program MANATEE YOURCHOICE HEALTH PLAN Health First New Health Bucks Program MANATEE YOURCHOICE HEALTH PLAN www.manateeyourchoice.com/healthfirst A special thanks to Aetna for covering the printing costs of this booklet. CONTENTS OUR PURPOSE

More information

Page 1. Disclosures. Background. No disclosures

Page 1. Disclosures. Background. No disclosures Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen

More information

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

ORIGINAL ARTICLE. Abstract. Introduction

ORIGINAL ARTICLE. Abstract. Introduction ORIGINAL ARTICLE Health Education Hokenshido Program Reduced Metabolic Syndrome in the Amagasaki Visceral Fat Study. Three-Year Follow-up Study of 3,174 Japanese Employees Miwa Ryo 1, Tadashi Nakamura

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

Correspondence should be addressed to Peng-Fei Shan;

Correspondence should be addressed to Peng-Fei Shan; International Endocrinology Volume 2016, Article ID 8483405, 7 pages http://dx.doi.org/10.1155/2016/8483405 Research Article Gender Differences in Risks of Coronary Heart Disease and Stroke in Patients

More information

Clinical Care Performance. Financial Year 2012 to 2018

Clinical Care Performance. Financial Year 2012 to 2018 Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c

More information

Regional of national clinical data. Do they help me to improve my practice? Rob Dijkstra, GP Dutch College of General Practitioners

Regional of national clinical data. Do they help me to improve my practice? Rob Dijkstra, GP Dutch College of General Practitioners Regional of national clinical data Do they help me to improve my practice? Rob Dijkstra, GP Dutch College of General Practitioners General practice outline How does it work in my practice? examples of

More information

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention?

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution

More information

Discussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting

Discussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting Session #5 Cardiometabolic Risk Management in the Primary Care Setting Sonja Reichert, MD MSc FCFP FACPM Betty Harvey, RNEC BScN MScN Amanda Mikalachki, RN BScN CDE S Discussion points Whom should we be

More information

Nutrition Care Process. Catherine Villafranca & Anthony Richitt

Nutrition Care Process. Catherine Villafranca & Anthony Richitt Nutrition Care Process Catherine Villafranca & Anthony Richitt Nutrition Care Process -According to eatrightpro.org, the Nutrition Care Process is a systematic approach to providing high-quality nutrition

More information

ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN?

ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN? ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN? W.H. OLDEWAGE-THERON & A.A. EGAL Centre of Sustainable Livelihoods, Vaal University of Technology,

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Identification of subjects at high risk for cardiovascular disease

Identification of subjects at high risk for cardiovascular disease Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet

More information

Put your Heart before your Head

Put your Heart before your Head Put your Heart before your Head Alok K Gupta, MD, FAAFP, FASH Associate Professor, Outpatient Clinic since 1963, the US Congress has required the President to proclaim February "American Heart Month."

More information

30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy

30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy Identifying Patients with Type 2 Diabetes at High Risk of Microalbuminuria: the DEMAND (Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in Diabetes) Study. Rossi

More information

Dr Anne King dc life dclife.co.uk

Dr Anne King dc life dclife.co.uk The Vampire Strikes Back Dr Anne King dc life dclife.co.uk Overview Clinical -v- Underwriting Blood physiology The blood sample Screening for the 3 main killers The top 3 useful blood tests The future

More information

Why are NICE guidelines and standards important and relevant to us?

Why are NICE guidelines and standards important and relevant to us? Why are NICE guidelines and standards important and relevant to us? Dr Liz England GP, Laurie Pike health centre RCGP Mental Health Clinical and Commissioning Lead SWB CCG Mental Health Lead NIHR Clinical

More information

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??

More information

6/10/2016. Hui-Chun Hsu

6/10/2016. Hui-Chun Hsu Hui-Chun Hsu PhD, RN, CDE Chief, Department of Diabetes Management Lee s Endocrinology Clinic Pingtung, Taiwan Disclosure to Participants Conflict of Interest (COI) and Financial Relationship Disclosures:

More information

Effect of Combined Interventions of Diet and Physical Activity on the Perceived and Actual Risk of Coronary

Effect of Combined Interventions of Diet and Physical Activity on the Perceived and Actual Risk of Coronary World Journal of Medical Sciences 9 (4): 282-288, 2013 ISSN 1817-3055 IDOSI Publications, 2013 DOI: 10.5829/idosi.wjms.2013.9.4.12383 Effect of Combined Interventions of Diet and Physical Activity on the

More information

Heart Age and Cardiovascular Risk

Heart Age and Cardiovascular Risk Heart Age and Cardiovascular Risk Mark Cobain Unilever R+D Colworth Science Park Sharnbrook Bedfordshire Europrevent, Geneva April 16 2011 Conflict of Interest Statement Employment by Unilever PLC A producer

More information

Evaluation of ischemia-modified albumin levels and parametersof arterial stiffness in patients with hypothyroidism

Evaluation of ischemia-modified albumin levels and parametersof arterial stiffness in patients with hypothyroidism Annals of Medical Research DOI: 10.5455/annalsmedres.2018.08.154 2019;26(1):32-6 Original Article Evaluation of ischemia-modified albumin levels and parametersof arterial stiffness in patients with Andac

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

Trends In CVD, Related Risk Factors, Prevention and Control In China

Trends In CVD, Related Risk Factors, Prevention and Control In China Trends In CVD, Related Risk Factors, Prevention and Control In China Youfa Wang, MD, MS, PhD Associate Professor Center for Human Nutrition Department of International Health Department of Epidemiology

More information

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2

More information

HEART RATE IN PATIENTS WITH CORONARY ARTERY DISEASE IN LATVIA

HEART RATE IN PATIENTS WITH CORONARY ARTERY DISEASE IN LATVIA Inga Balode HEART RATE IN PATIENTS WITH CORONARY ARTERY DISEASE IN LATVIA Summary of the Doctoral Thesis for obtaining the degree of a Doctor of Medicine Speciality Internal Medicine Riga, 2014 Doctoral

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Patient Education. intermountainhealthcare.org/diabetes. BG Tracker. for people with diabetes MONITORING BLOOD GLUCOSE

Patient Education. intermountainhealthcare.org/diabetes. BG Tracker. for people with diabetes MONITORING BLOOD GLUCOSE Patient Education intermountainhealthcare.org/diabetes Tracker for people with diabetes MONITORING BLOOD GLUCOSE Title Case My name/phone: Contact numbers: Healthcare provider: Diabetes educator: Pharmacy:

More information

Abstract. Research Methods. Muneer Mohammad Bustanji (1) Sawsan Majali (2)

Abstract. Research Methods. Muneer Mohammad Bustanji (1) Sawsan Majali (2) Effect of Combined Interventions of Diet and Physical Activity on the Perceived and Actual Risk of Coronary Heart Disease among Women in North of Jordan Muneer Mohammad Bustanji (1) Sawsan Majali (2) (1)

More information

American Journal of Oral Medicine and Radiology

American Journal of Oral Medicine and Radiology American Journal of Oral Medicine and Radiology e - ISSN - XXXX-XXXX ISSN - 2394-7721 Journal homepage: www.mcmed.us/journal/ajomr PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE AMONG TYPE 2 DIABETIC POPULATION

More information

The Clinical Debates

The Clinical Debates The Clinical Debates Speakers: Round 2: Statins for Primary Prevention of Cardiovascular Disease Matthew Cantrell, PharmD, BCPS, is a 2000 graduate of Mt. Mercy College and 2005 graduate from the University

More information

Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers

Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers Nada Abu-Kishk Health Nutrition Officer at UNRWA-HQ What is UNRWA (United Nations

More information

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of

More information

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet

More information

ANNUAL HEALTH CHECKUP BASIC HEALTH PACKAGE

ANNUAL HEALTH CHECKUP BASIC HEALTH PACKAGE ANNUAL HEALTH CHECKUP Taking care of your health is our responsibility and to make sure that you remain at a distance from the serious maladies, we also step forward in providing health checkups. This

More information

Methods. Background and Objectives STRADIVARIUS

Methods. Background and Objectives STRADIVARIUS STRADIVARIUS Effect of on Progression of Atherosclerosis in Patients with Abdominal Obesity and Coronary Artery Disease Steven E. Nissen MD Stephen J. Nicholls MBBS PhD, Kathy Wolski MPH, Josep Rodés-Cabau

More information

Abstract. (Left Mouse-click to begin and move to next slide.)

Abstract. (Left Mouse-click to begin and move to next slide.) Abstract (Left Mouse-click to begin and move to next slide.) A Comparison of Pulse Pressure, Arterial Stiffness, and Endothelial Function for the Diagnosis and Prognostic Risk of Coronary Heart Disease

More information

Health Indicators and Status in the European Union

Health Indicators and Status in the European Union Elmadfa I,Weichselbaum E (eds): European Nutrition and Health Report 4. Forum Nutr. Basel, Karger, 5, vol 58, pp 47 61 Health Indicators and Status in the European Prevalence of Overweight and Obesity

More information

Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance.

Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance. ORIGINAL ARTICLE Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance. Bonneau GA y Pedrozo WR 1 Ministry of Public Health, Province of Misiones, 2 School of Exact, Chemical

More information